Search

everythinglearnresearchcommunity

for

Search:↓

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Older patients sticking to their prostate medication saw lasting health benefits.

The normal human prostate does not significantly affect blood DHT levels.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Serenoa repens may help with prostate issues, but more research is needed to confirm its effectiveness.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Finasteride may reduce prostate cancer risk.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.